Beta Bionics Stock

betabionics.comHealthcare / Medical DevicesFounded: 2015Funding to Date: $132MM

Beta Bionics, founded in 2015, is a medical technology company, and the creator of a bionic pancreas that aims to make diabetes care more manageable. Their iLet Bionic Pancreas is an automated insulin delivery system that can calculate doses, aiming to reduce the need for users to make decisions about their diabetes management.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Beta Bionics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Beta Bionics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Beta Bionics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Toby Milgrome
Co-Founder
Edward Damiano
Founder, President & Chief Executive Officer
Firas El-Khatib Ph.D
Co-Founder & Vice President, Autonomous Systems
Serafina Raskin
Vice President, Corporate Secretary & General Counsel
Stephen Feider
Chief Financial Officer
Steve Russell Ph.D
Chief Medical Officer

Board Members

Christian Foged
Novo Nordisk
Finny Kuruvilla Ph.D
Eventide Asset Management

Beta Bionics stock FAQs

plusminus

Can you buy Beta Bionics stock?

As Beta Bionics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Beta Bionics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Beta Bionics stock?

To invest in a private company like Beta Bionics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Beta Bionics stock?

Yes, you may be able to sell your Beta Bionics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Beta Bionics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Beta Bionics stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Beta Bionics a public company?

No, Beta Bionics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Beta Bionics’ stock price?

Beta Bionics is a privately held company and therefore does not have a public stock price. However, you may access Beta Bionics’ private market stock price with Forge Data.
plusminus

What is Beta Bionics’ stock ticker symbol?

Beta Bionics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
In the wake of earning FDA clearance for its insulin pump and automated dosing software—which connect to a Dexcom continuous glucose monitor to create what’s known as a hybrid closed-loop system for diabetes management—Beta Bionics is raking in the dough. The Massachusetts-based company has pooled $100 million in series D equity funding, it announced this week.
Artificial pancreas systems synchronize an insulin pump and continuous glucose monitor with the goal of delivering an almost completely hands-off approach to diabetes management—and the newest one cleared by the FDA aims to make that goal even easier to achieve.
The iLet is a pocket-sized, wearable investigational medical device that autonomously controls blood sugar in people with diabetes and other conditions --...
Boston-based Beta Bionics said this week that it closed a $63 million Series B round to support the development of its iLet bionic pancreas system for people with Type 1 diabetes. The company’s iLet device features an autonomous, dual-chamber infusion pump that is powered by dosing algorithms. Using machine learning and data from a continuous glucose monitor, […]
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.